• SENSEX
    NIFTY 50
Business

Sun Pharma started 2018 with a bang and is ending it on a whimper. What went wrong?

Updated : December 03, 2018 01:21 PM IST

The shadow of USFDA on its multi-dosage Halol facility — the American drug regulator’s warning on quality control violation at the plant had remained since 2015 — lifted this year. 
While operational performance was in line with expectations, revenues missed targets. Revenue grew 4.3 percent year-on-year compared with estimates of a 17 percent growth.
Sun Pharma started 2018 with a bang and is ending it on a whimper. What went wrong?
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV